Table of Content 1 Introduction 1.1 Objective of the Study 1.2 Definition of the Market 1.3 Market Scope 1.3.1 Market Segment by Type, Application and Marketing Channel 1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa) 1.4 Years Considered for the Study (2014-2026) 1.5 Currency Considered (U.S. Dollar) 1.6 Stakeholders 2 Key Findings of the Study 3 Market Dynamics 3.1 Driving Factors for this Market 3.2 Factors Challenging the Market 3.3 Opportunities of the Global Duchenne Muscular Dystrophy Drugs Market (Regions, Growing/Emerging Downstream Market Analysis) 3.4 Technological and Market Developments in the Duchenne Muscular Dystrophy Drugs Market 3.5 Industry News by Region 3.6 Regulatory Scenario by Region/Country 3.7 Market Investment Scenario Strategic Recommendations Analysis 4 Value Chain of the Duchenne Muscular Dystrophy Drugs Market 4.1 Value Chain Status 4.2 Upstream Raw Material Analysis 4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type) 4.4 Distributors/Traders 4.5 Downstream Major Customer Analysis (by Region) 5 Global Duchenne Muscular Dystrophy Drugs Market-Segmentation by Type 5.1 Exondys51 5.2 Translarna 5.3 Emflaza 6 Global Duchenne Muscular Dystrophy Drugs Market-Segmentation by Application 6.1 Hospitals 6.2 Home care settings 6.3 Clinics 7 Global Duchenne Muscular Dystrophy Drugs Market-Segmentation by Marketing Channel 7.1 Traditional Marketing Channel (Offline) 7.2 Online Channel 8 Competitive Intelligence – Company Profiles 8.1 Akashi Therapeutics 8.1.1 Akashi Therapeutics Profile 8.1.2 Akashi Therapeutics Sales, Growth Rate and Global Market Share from 2014-2019E 8.1.3 Akashi Therapeutics Product/Solution Launches and Enhancements Analysis 8.1.4 Akashi Therapeutics Business Overview/Recent Development/Acquisitions 8.2 BioMarin Pharmaceutical 8.2.1 BioMarin Pharmaceutical Profile 8.2.2 BioMarin Pharmaceutical Sales, Growth Rate and Global Market Share from 2014-2019E 8.2.3 BioMarin Pharmaceutical Product/Solution Launches and Enhancements Analysis 8.2.4 BioMarin Pharmaceutical Business Overview/Recent Development/Acquisitions 8.3 Taiho Pharmaceutical 8.3.1 Taiho Pharmaceutical Profile 8.3.2 Taiho Pharmaceutical Sales, Growth Rate and Global Market Share from 2014-2019E 8.3.3 Taiho Pharmaceutical Product/Solution Launches and Enhancements Analysis 8.3.4 Taiho Pharmaceutical Business Overview/Recent Development/Acquisitions 8.4 Acceleron Pharma 8.4.1 Acceleron Pharma Profile 8.4.2 Acceleron Pharma Sales, Growth Rate and Global Market Share from 2014-2019E 8.4.3 Acceleron Pharma Product/Solution Launches and Enhancements Analysis 8.4.4 Acceleron Pharma Business Overview/Recent Development/Acquisitions 8.5 Italfarmaco 8.5.1 Italfarmaco Profile 8.5.2 Italfarmaco Sales, Growth Rate and Global Market Share from 2014-2019E 8.5.3 Italfarmaco Product/Solution Launches and Enhancements Analysis 8.5.4 Italfarmaco Business Overview/Recent Development/Acquisitions 8.6 Nobelpharma 8.6.1 Nobelpharma Profile 8.6.2 Nobelpharma Sales, Growth Rate and Global Market Share from 2014-2019E 8.6.3 Nobelpharma Product/Solution Launches and Enhancements Analysis 8.6.4 Nobelpharma Business Overview/Recent Development/Acquisitions 8.7 Eli Lilly 8.7.1 Eli Lilly Profile 8.7.2 Eli Lilly Sales, Growth Rate and Global Market Share from 2014-2019E 8.7.3 Eli Lilly Product/Solution Launches and Enhancements Analysis 8.7.4 Eli Lilly Business Overview/Recent Development/Acquisitions 8.8 Marathon Pharmaceuticals 8.8.1 Marathon Pharmaceuticals Profile 8.8.2 Marathon Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2019E 8.8.3 Marathon Pharmaceuticals Product/Solution Launches and Enhancements Analysis 8.8.4 Marathon Pharmaceuticals Business Overview/Recent Development/Acquisitions 8.9 Summit Therapeutics 8.9.1 Summit Therapeutics Profile 8.9.2 Summit Therapeutics Sales, Growth Rate and Global Market Share from 2014-2019E 8.9.3 Summit Therapeutics Product/Solution Launches and Enhancements Analysis 8.9.4 Summit Therapeutics Business Overview/Recent Development/Acquisitions 8.10 Nippon Shinyaku 8.10.1 Nippon Shinyaku Profile 8.10.2 Nippon Shinyaku Sales, Growth Rate and Global Market Share from 2014-2019E 8.10.3 Nippon Shinyaku Product/Solution Launches and Enhancements Analysis 8.10.4 Nippon Shinyaku Business Overview/Recent Development/Acquisitions 8.11 Bristol-Myers Squibb 8.11.1 Bristol-Myers Squibb Profile 8.11.2 Bristol-Myers Squibb Sales, Growth Rate and Global Market Share from 2014-2019E 8.11.3 Bristol-Myers Squibb Product/Solution Launches and Enhancements Analysis 8.11.4 Bristol-Myers Squibb Business Overview/Recent Development/Acquisitions 8.12 Pfizer 8.12.1 Pfizer Profile 8.12.2 Pfizer Sales, Growth Rate and Global Market Share from 2014-2019E 8.12.3 Pfizer Product/Solution Launches and Enhancements Analysis 8.12.4 Pfizer Business Overview/Recent Development/Acquisitions 8.13 Lexicon Pharmaceuticals 8.13.1 Lexicon Pharmaceuticals Profile 8.13.2 Lexicon Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2019E 8.13.3 Lexicon Pharmaceuticals Product/Solution Launches and Enhancements Analysis 8.13.4 Lexicon Pharmaceuticals Business Overview/Recent Development/Acquisitions 8.14 Janssen Pharmaceuticals 8.14.1 Janssen Pharmaceuticals Profile 8.14.2 Janssen Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2019E 8.14.3 Janssen Pharmaceuticals Product/Solution Launches and Enhancements Analysis 8.14.4 Janssen Pharmaceuticals Business Overview/Recent Development/Acquisitions 8.15 Asklepios BioPharmaceuticals 8.15.1 Asklepios BioPharmaceuticals Profile 8.15.2 Asklepios BioPharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2019E 8.15.3 Asklepios BioPharmaceuticals Product/Solution Launches and Enhancements Analysis 8.15.4 Asklepios BioPharmaceuticals Business Overview/Recent Development/Acquisitions 8.16 Sarepta Therapeutics 8.16.1 Sarepta Therapeutics Profile 8.16.2 Sarepta Therapeutics Sales, Growth Rate and Global Market Share from 2014-2019E 8.16.3 Sarepta Therapeutics Product/Solution Launches and Enhancements Analysis 8.16.4 Sarepta Therapeutics Business Overview/Recent Development/Acquisitions 8.17 Catabasis Pharmaceuticals 8.17.1 Catabasis Pharmaceuticals Profile 8.17.2 Catabasis Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2019E 8.17.3 Catabasis Pharmaceuticals Product/Solution Launches and Enhancements Analysis 8.17.4 Catabasis Pharmaceuticals Business Overview/Recent Development/Acquisitions 8.18 Capricor Therapeutics 8.18.1 Capricor Therapeutics Profile 8.18.2 Capricor Therapeutics Sales, Growth Rate and Global Market Share from 2014-2019E 8.18.3 Capricor Therapeutics Product/Solution Launches and Enhancements Analysis 8.18.4 Capricor Therapeutics Business Overview/Recent Development/Acquisitions 8.19 Santhera Pharmaceuticals 8.19.1 Santhera Pharmaceuticals Profile 8.19.2 Santhera Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2019E 8.19.3 Santhera Pharmaceuticals Product/Solution Launches and Enhancements Analysis 8.19.4 Santhera Pharmaceuticals Business Overview/Recent Development/Acquisitions 8.20 PTC Therapeutics 8.20.1 PTC Therapeutics Profile 8.20.2 PTC Therapeutics Sales, Growth Rate and Global Market Share from 2014-2019E 8.20.3 PTC Therapeutics Product/Solution Launches and Enhancements Analysis 8.20.4 PTC Therapeutics Business Overview/Recent Development/Acquisitions 9 Global Duchenne Muscular Dystrophy Drugs Market-Segmentation by Geography 10 North America 10.1 North America Duchenne Muscular Dystrophy Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 10.2 North America Duchenne Muscular Dystrophy Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 10.3 North America Duchenne Muscular Dystrophy Drugs Production Analysis from 2014-2019E 10.4 North America Duchenne Muscular Dystrophy Drugs Consumption Analysis from 2014-2019E 10.5 North America Duchenne Muscular Dystrophy Drugs Import and Export from 2014-2019E 10.6 North America Duchenne Muscular Dystrophy Drugs Value, Production and Market Share by Type (2014-2019E) 10.7 North America Duchenne Muscular Dystrophy Drugs Consumption, Value and Market Share by Application (2014-2019E) 10.8 North America Duchenne Muscular Dystrophy Drugs by Country (United States, Canada) 10.8.1 North America Duchenne Muscular Dystrophy Drugs Sales by Country (2014-2019E) 10.8.2 North America Duchenne Muscular Dystrophy Drugs Consumption Value by Country (2014-2019E) 10.9 North America Duchenne Muscular Dystrophy Drugs Market PEST Analysis 11 Europe 11.1 Europe Duchenne Muscular Dystrophy Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 11.2 Europe Duchenne Muscular Dystrophy Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 11.3 Europe Duchenne Muscular Dystrophy Drugs Production Analysis from 2014-2019E 11.4 Europe Duchenne Muscular Dystrophy Drugs Consumption Analysis from 2014-2019E 11.5 Europe Duchenne Muscular Dystrophy Drugs Import and Export from 2014-2019E 11.6 Europe Duchenne Muscular Dystrophy Drugs Value, Production and Market Share by Type (2014-2019E) 11.7 Europe Duchenne Muscular Dystrophy Drugs Consumption, Value and Market Share by Application (2014-2019E) 11.8 Europe Duchenne Muscular Dystrophy Drugs by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium) 11.8.1 Europe Duchenne Muscular Dystrophy Drugs Sales by Country (2014-2019E) 11.8.2 Europe Duchenne Muscular Dystrophy Drugs Consumption Value by Country (2014-2019E) 11.9 Europe Duchenne Muscular Dystrophy Drugs Market PEST Analysis 12 Asia-Pacific 12.1 Asia-Pacific Duchenne Muscular Dystrophy Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 12.2 Asia-Pacific Duchenne Muscular Dystrophy Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 12.3 Asia-Pacific Duchenne Muscular Dystrophy Drugs Production Analysis from 2014-2019E 12.4 Asia-Pacific Duchenne Muscular Dystrophy Drugs Consumption Analysis from 2014-2019E 12.5 Asia-Pacific Duchenne Muscular Dystrophy Drugs Import and Export from 2014-2019E 12.6 Asia-Pacific Duchenne Muscular Dystrophy Drugs Value, Production and Market Share by Type (2014-2019E) 12.7 Asia-Pacific Duchenne Muscular Dystrophy Drugs Consumption, Value and Market Share by Application (2014-2019E) 12.8 Asia-Pacific Duchenne Muscular Dystrophy Drugs by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia) 12.8.1 Asia-Pacific Duchenne Muscular Dystrophy Drugs Sales by Country (2014-2019E) 12.8.2 Asia-Pacific Duchenne Muscular Dystrophy Drugs Consumption Value by Country (2014-2019E) 12.9 Asia-Pacific Duchenne Muscular Dystrophy Drugs Market PEST Analysis 13 Latin America 13.1 Latin America Duchenne Muscular Dystrophy Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 13.2 Latin America Duchenne Muscular Dystrophy Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 13.3 Latin America Duchenne Muscular Dystrophy Drugs Production Analysis from 2014-2019E 13.4 Latin America Duchenne Muscular Dystrophy Drugs Consumption Analysis from 2014-2019E 13.5 Latin America Duchenne Muscular Dystrophy Drugs Import and Export from 2014-2019E 13.6 Latin America Duchenne Muscular Dystrophy Drugs Value, Production and Market Share by Type (2014-2019E) 13.7 Latin America Duchenne Muscular Dystrophy Drugs Consumption, Value and Market Share by Application (2014-2019E) 13.8 Latin America Duchenne Muscular Dystrophy Drugs by Country (Brazil, Mexico, Argentina, Columbia, Chile) 13.8.1 Latin America Duchenne Muscular Dystrophy Drugs Sales by Country (2014-2019E) 13.8.2 Latin America Duchenne Muscular Dystrophy Drugs Consumption Value by Country (2014-2019E) 13.9 Latin America Duchenne Muscular Dystrophy Drugs Market PEST Analysis 14 Middle East & Africa 14.1 Middle East & Africa Duchenne Muscular Dystrophy Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 14.2 Middle East & Africa Duchenne Muscular Dystrophy Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 14.3 Middle East & Africa Duchenne Muscular Dystrophy Drugs Production Analysis from 2014-2019E 14.4 Middle East & Africa Duchenne Muscular Dystrophy Drugs Consumption Analysis from 2014-2019E 14.5 Middle East & Africa Duchenne Muscular Dystrophy Drugs Import and Export from 2014-2019E 14.6 Middle East & Africa Duchenne Muscular Dystrophy Drugs Value, Production and Market Share by Type (2014-2019E) 14.7 Middle East & Africa Duchenne Muscular Dystrophy Drugs Consumption, Value and Market Share by Application (2014-2019E) 14.8 Middle East & Africa Duchenne Muscular Dystrophy Drugs by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa) 14.8.1 Middle East & Africa Duchenne Muscular Dystrophy Drugs Sales by Country (2014-2019E) 14.8.2 Middle East & Africa Duchenne Muscular Dystrophy Drugs Consumption Value by Country (2014-2019E) 14.9 Middle East & Africa Duchenne Muscular Dystrophy Drugs Market PEST Analysis 15 Future Forecast of the Global Duchenne Muscular Dystrophy Drugs Market from 2018-2026 15.1 Future Forecast of the Global Duchenne Muscular Dystrophy Drugs Market from 2019-2026 Segment by Region 15.2 Global Duchenne Muscular Dystrophy Drugs Production and Growth Rate Forecast by Type (2019-2026) 15.3 Global Duchenne Muscular Dystrophy Drugs Consumption and Growth Rate Forecast by Application (2019-2026) 16 Appendix 16.1 Methodology 16.2 Research Data Source

List of Tables and Figures Global Duchenne Muscular Dystrophy Drugs Market Value ($) and Growth Rate of Duchenne Muscular Dystrophy Drugs from 2014-2026 Global Duchenne Muscular Dystrophy Drugs Production and Growth Rate Segment by Product Type from 2014-2026F Global Duchenne Muscular Dystrophy Drugs Consumption and Growth Rate Segment by Application from 2014-2019E Figure Duchenne Muscular Dystrophy Drugs Picture Table Product Specifications of Duchenne Muscular Dystrophy Drugs Table Driving Factors for this Market Table Industry News of Duchenne Muscular Dystrophy Drugs Market Figure Value Chain Status of Duchenne Muscular Dystrophy Drugs Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type) Table Distributors/Traders Table Downstream Major Customer Analysis (by Region, by Preference) Table Global Duchenne Muscular Dystrophy Drugs Production and Growth Rate Segment by Product Type from 2014-2019E Table Global Duchenne Muscular Dystrophy Drugs Value ($) and Growth Rate Segment by Product Type from 2014-2019E Figure Exondys51 of Duchenne Muscular Dystrophy Drugs Figure Translarna of Duchenne Muscular Dystrophy Drugs Figure Emflaza of Duchenne Muscular Dystrophy Drugs Table Global Duchenne Muscular Dystrophy Drugs Consumption and Growth Rate Segment by Application from 2014-2019E Table Global Duchenne Muscular Dystrophy Drugs Value ($) and Growth Rate Segment by Application from 2014-2019E Figure Hospitals of Duchenne Muscular Dystrophy Drugs Figure Home care settings of Duchenne Muscular Dystrophy Drugs Figure Clinics of Duchenne Muscular Dystrophy Drugs Table Global Duchenne Muscular Dystrophy Drugs Consumption and Growth Rate Segment by Marketing Channel from 2014-2019E Table Global Duchenne Muscular Dystrophy Drugs Value ($) and Growth Rate Segment by Marketing Channel from 2014-2019E Figure Traditional Marketing Channel (Offline) of Duchenne Muscular Dystrophy Drugs Figure Online Channel of Duchenne Muscular Dystrophy Drugs Table Akashi Therapeutics Profile (Company Name, Plants Distribution, Sales Region) Figure Akashi Therapeutics Sales and Growth Rate from 2014-2019E Figure Akashi Therapeutics Revenue ($) and Global Market Share from 2014-2019E Table Akashi Therapeutics Duchenne Muscular Dystrophy Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table BioMarin Pharmaceutical Profile (Company Name, Plants Distribution, Sales Region) Figure BioMarin Pharmaceutical Sales and Growth Rate from 2014-2019E Figure BioMarin Pharmaceutical Revenue ($) and Global Market Share from 2014-2019E Table BioMarin Pharmaceutical Duchenne Muscular Dystrophy Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Taiho Pharmaceutical Profile (Company Name, Plants Distribution, Sales Region) Figure Taiho Pharmaceutical Sales and Growth Rate from 2014-2019E Figure Taiho Pharmaceutical Revenue ($) and Global Market Share from 2014-2019E Table Taiho Pharmaceutical Duchenne Muscular Dystrophy Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Acceleron Pharma Profile (Company Name, Plants Distribution, Sales Region) Figure Acceleron Pharma Sales and Growth Rate from 2014-2019E Figure Acceleron Pharma Revenue ($) and Global Market Share from 2014-2019E Table Acceleron Pharma Duchenne Muscular Dystrophy Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Italfarmaco Profile (Company Name, Plants Distribution, Sales Region) Figure Italfarmaco Sales and Growth Rate from 2014-2019E Figure Italfarmaco Revenue ($) and Global Market Share from 2014-2019E Table Italfarmaco Duchenne Muscular Dystrophy Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Nobelpharma Profile (Company Name, Plants Distribution, Sales Region) Figure Nobelpharma Sales and Growth Rate from 2014-2019E Figure Nobelpharma Revenue ($) and Global Market Share from 2014-2019E Table Nobelpharma Duchenne Muscular Dystrophy Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Eli Lilly Profile (Company Name, Plants Distribution, Sales Region) Figure Eli Lilly Sales and Growth Rate from 2014-2019E Figure Eli Lilly Revenue ($) and Global Market Share from 2014-2019E Table Eli Lilly Duchenne Muscular Dystrophy Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Marathon Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region) Figure Marathon Pharmaceuticals Sales and Growth Rate from 2014-2019E Figure Marathon Pharmaceuticals Revenue ($) and Global Market Share from 2014-2019E Table Marathon Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Summit Therapeutics Profile (Company Name, Plants Distribution, Sales Region) Figure Summit Therapeutics Sales and Growth Rate from 2014-2019E Figure Summit Therapeutics Revenue ($) and Global Market Share from 2014-2019E Table Summit Therapeutics Duchenne Muscular Dystrophy Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Nippon Shinyaku Profile (Company Name, Plants Distribution, Sales Region) Figure Nippon Shinyaku Sales and Growth Rate from 2014-2019E Figure Nippon Shinyaku Revenue ($) and Global Market Share from 2014-2019E Table Nippon Shinyaku Duchenne Muscular Dystrophy Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Bristol-Myers Squibb Profile (Company Name, Plants Distribution, Sales Region) Figure Bristol-Myers Squibb Sales and Growth Rate from 2014-2019E Figure Bristol-Myers Squibb Revenue ($) and Global Market Share from 2014-2019E Table Bristol-Myers Squibb Duchenne Muscular Dystrophy Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Pfizer Profile (Company Name, Plants Distribution, Sales Region) Figure Pfizer Sales and Growth Rate from 2014-2019E Figure Pfizer Revenue ($) and Global Market Share from 2014-2019E Table Pfizer Duchenne Muscular Dystrophy Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Lexicon Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region) Figure Lexicon Pharmaceuticals Sales and Growth Rate from 2014-2019E Figure Lexicon Pharmaceuticals Revenue ($) and Global Market Share from 2014-2019E Table Lexicon Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Janssen Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region) Figure Janssen Pharmaceuticals Sales and Growth Rate from 2014-2019E Figure Janssen Pharmaceuticals Revenue ($) and Global Market Share from 2014-2019E Table Janssen Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Asklepios BioPharmaceuticals Profile (Company Name, Plants Distribution, Sales Region) Figure Asklepios BioPharmaceuticals Sales and Growth Rate from 2014-2019E Figure Asklepios BioPharmaceuticals Revenue ($) and Global Market Share from 2014-2019E Table Asklepios BioPharmaceuticals Duchenne Muscular Dystrophy Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Sarepta Therapeutics Profile (Company Name, Plants Distribution, Sales Region) Figure Sarepta Therapeutics Sales and Growth Rate from 2014-2019E Figure Sarepta Therapeutics Revenue ($) and Global Market Share from 2014-2019E Table Sarepta Therapeutics Duchenne Muscular Dystrophy Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Catabasis Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region) Figure Catabasis Pharmaceuticals Sales and Growth Rate from 2014-2019E Figure Catabasis Pharmaceuticals Revenue ($) and Global Market Share from 2014-2019E Table Catabasis Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Capricor Therapeutics Profile (Company Name, Plants Distribution, Sales Region) Figure Capricor Therapeutics Sales and Growth Rate from 2014-2019E Figure Capricor Therapeutics Revenue ($) and Global Market Share from 2014-2019E Table Capricor Therapeutics Duchenne Muscular Dystrophy Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Santhera Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region) Figure Santhera Pharmaceuticals Sales and Growth Rate from 2014-2019E Figure Santhera Pharmaceuticals Revenue ($) and Global Market Share from 2014-2019E Table Santhera Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table PTC Therapeutics Profile (Company Name, Plants Distribution, Sales Region) Figure PTC Therapeutics Sales and Growth Rate from 2014-2019E Figure PTC Therapeutics Revenue ($) and Global Market Share from 2014-2019E Table PTC Therapeutics Duchenne Muscular Dystrophy Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Global Duchenne Muscular Dystrophy Drugs Production Value ($) by Region from 2014-2019E Table Global Duchenne Muscular Dystrophy Drugs Production Value Share by Region from 2014-2019E Table Global Duchenne Muscular Dystrophy Drugs Production by Region from 2014-2019E Table Global Duchenne Muscular Dystrophy Drugs Consumption Value ($) by Region from 2014-2019E Table Global Duchenne Muscular Dystrophy Drugs Consumption by Region from 2014-2019E Table North America Duchenne Muscular Dystrophy Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table North America Duchenne Muscular Dystrophy Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table North America Duchenne Muscular Dystrophy Drugs Import and Export from 2014-2019E Table North America Duchenne Muscular Dystrophy Drugs Value ($) by Type (2014-2019E) Table North America Duchenne Muscular Dystrophy Drugs Production by Type (2014-2019E) Table North America Duchenne Muscular Dystrophy Drugs Consumption by Application (2014-2019E) Table North America Duchenne Muscular Dystrophy Drugs Consumption by Country (2014-2019E) Table North America Duchenne Muscular Dystrophy Drugs Consumption Value ($) by Country (2014-2019E) Figure North America Duchenne Muscular Dystrophy Drugs Market PEST Analysis Table Europe Duchenne Muscular Dystrophy Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Europe Duchenne Muscular Dystrophy Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Europe Duchenne Muscular Dystrophy Drugs Import and Export from 2014-2019E Table Europe Duchenne Muscular Dystrophy Drugs Value ($) by Type (2014-2019E) Table Europe Duchenne Muscular Dystrophy Drugs Production by Type (2014-2019E) Table Europe Duchenne Muscular Dystrophy Drugs Consumption by Application (2014-2019E) Table Europe Duchenne Muscular Dystrophy Drugs Consumption by Country (2014-2019E) Table Europe Duchenne Muscular Dystrophy Drugs Consumption Value ($) by Country (2014-2019E) Figure Europe Duchenne Muscular Dystrophy Drugs Market PEST Analysis Table Asia-Pacific Duchenne Muscular Dystrophy Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Asia-Pacific Duchenne Muscular Dystrophy Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Asia-Pacific Duchenne Muscular Dystrophy Drugs Import and Export from 2014-2019E Table Asia-Pacific Duchenne Muscular Dystrophy Drugs Value ($) by Type (2014-2019E) Table Asia-Pacific Duchenne Muscular Dystrophy Drugs Production by Type (2014-2019E) Table Asia-Pacific Duchenne Muscular Dystrophy Drugs Consumption by Application (2014-2019E) Table Asia-Pacific Duchenne Muscular Dystrophy Drugs Consumption by Country (2014-2019E) Table Asia-Pacific Duchenne Muscular Dystrophy Drugs Consumption Value ($) by Country (2014-2019E) Figure Asia-Pacific Duchenne Muscular Dystrophy Drugs Market PEST Analysis Table Latin America Duchenne Muscular Dystrophy Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Latin America Duchenne Muscular Dystrophy Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Latin America Duchenne Muscular Dystrophy Drugs Import and Export from 2014-2019E Table Latin America Duchenne Muscular Dystrophy Drugs Value ($) by Type (2014-2019E) Table Latin America Duchenne Muscular Dystrophy Drugs Production by Type (2014-2019E) Table Latin America Duchenne Muscular Dystrophy Drugs Consumption by Application (2014-2019E) Table Latin America Duchenne Muscular Dystrophy Drugs Consumption by Country (2014-2019E) Table Latin America Duchenne Muscular Dystrophy Drugs Consumption Value ($) by Country (2014-2019E) Figure Latin America Duchenne Muscular Dystrophy Drugs Market PEST Analysis Table Middle East & Africa Duchenne Muscular Dystrophy Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Middle East & Africa Duchenne Muscular Dystrophy Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Middle East & Africa Duchenne Muscular Dystrophy Drugs Import and Export from 2014-2019E Table Middle East & Africa Duchenne Muscular Dystrophy Drugs Value ($) by Type (2014-2019E) Table Middle East & Africa Duchenne Muscular Dystrophy Drugs Production by Type (2014-2019E) Table Middle East & Africa Duchenne Muscular Dystrophy Drugs Consumption by Application (2014-2019E) Table Middle East & Africa Duchenne Muscular Dystrophy Drugs Consumption by Country (2014-2019E) Table Middle East & Africa Duchenne Muscular Dystrophy Drugs Consumption Value ($) by Country (2014-2019E) Figure Middle East & Africa Duchenne Muscular Dystrophy Drugs Market PEST Analysis Table Global Duchenne Muscular Dystrophy Drugs Value ($) and Growth Rate Forecast by Region (2018-2026) Table Global Duchenne Muscular Dystrophy Drugs Production and Growth Rate Forecast by Region (2019-2026) Table Global Duchenne Muscular Dystrophy Drugs Consumption and Growth Rate Forecast by Region (2019-2026) Table Global Duchenne Muscular Dystrophy Drugs Production and Growth Rate Forecast by Type (2019-2026) Table Global Duchenne Muscular Dystrophy Drugs Consumption and Growth Rate Forecast by Application (2019-2026)